1 - 7 toradh á dtaispeáint as 7 toradh san iomlán ar an gcuardach 'Juha P. Himanen (14851154)', am iarratais: 0.01s Beachtaigh na torthaí
  1. 1
    Supplementary Table S4 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy

    Supplementary Table S4 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy de réir Amr El Zawily (14851115)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Supplementary Table S7 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy

    Supplementary Table S7 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy de réir Amr El Zawily (14851115)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Supplementary Table S5 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy

    Supplementary Table S5 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy de réir Amr El Zawily (14851115)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Supplementary Table S3 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy

    Supplementary Table S3 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy de réir Amr El Zawily (14851115)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Supplementary Table S6 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy

    Supplementary Table S6 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy de réir Amr El Zawily (14851115)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Supplementary Table S1 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy

    Supplementary Table S1 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy de réir Amr El Zawily (14851115)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Supplementary Table S2 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy

    Supplementary Table S2 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy de réir Amr El Zawily (14851115)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: